Navigation Links
Small Stem Cell Study Claims Early Success in Treating Eye Disease
Date:1/23/2012

MONDAY, Jan. 23 (HealthDay News) -- Using human embryonic stem cells to treat the eye disease macular degeneration appears to be safe and leads to some vision improvement, a small, early-stage study found.

The study included one elderly patient and one younger adult patient with different types of macular degeneration that had led to severe vision loss.

After four months, the embryonic stem cell transplants seemed safe and both patients had some improvement in vision, the U.S. researchers said.

The study, published online Jan. 23 in The Lancet, is the first report of the use of human embryonic stem cells (hESC) in humans for any purpose, the researchers said in a news release from the journal.

One patient was a woman in her 70s with dry age-related macular degeneration (AMD), which is the leading cause of blindness in the developed world. The other patient was a woman in her 50s with Stargardt's macular dystrophy, the most common type of macular degeneration in younger patients. Both were legally blind.

Both patients received transplants of retinal pigment epithelium (RPE) derived from human embryonic stem cells into what's called the subretinal space (under the retina of the eye) in one eye. The patients received low-dose immunosuppression therapy, which was gradually reduced after six weeks.

Follow-up exams showed that the transplanted cells had attached to a part of the retina called Bruch's membrane and survived throughout the study period. Four months after transplant, there were no signs of so-called teratoma formation -- which occurs when stem cells turn into multiple cell types and form "incompatible" tissues that can include teeth and hair -- or related problems. And there were no signs of rejection or abnormal cell growth, the researchers said.

"Our study is designed to test the safety and tolerability of hESC-RPE in patients with advanced-stage Stargardt's macular dystrophy and
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
2. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
3. Small Increase in Diabetes Risk Noted in Statin Patients
4. Small to Mid-Sized Hospitals Turn to Orion Health to Implement Health IT Solutions for Improved Patient Care and Outcomes
5. Media, small businesses invited to ACS Webinar on ways to take advantage of Chinas dynamic growth
6. Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program
7. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
8. Small Dogs Traced Back to Middle Eastern Wolf
9. Landrieu Comments on Presidents Small Business Health Care Report
10. Small molecule with high impact
11. A Small Grass-roots Non-profit, Announces That They Haven't Gone Away and are Still Alive with Helping the Disadvantaged Children in Ukraine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... in the United Kingdom have determined that azithromycin, ... can be an effective treatment option for patients ... complication that occurs in the majority of patients ... leading cause of mortality after the first year ... body repeatedly rejects the transplanted lung tissue. The ...
(Date:5/22/2012)... Children born with cleft lip, cleft palate and ... appearance. , Patients can face serious airway, feeding, ... and psychological challenges, Laura Swibel Rosenthal, MD, of ... the June 2012 issue of Otolaryngologic Clinics ... patients with craniofacial syndromes is complex," Rosenthal and ...
(Date:5/22/2012)... -- Researchers at Barrow Neurological Institute at St. ... and why the public perceives some magic tricks ... in military tactics, marketing and sports. , Susana ... and Stephen Macknik, PhD, of Barrow,s Laboratory of ... into magic and illusions. Their most recent original ...
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Barrow researchers use magic for discoveries 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3
... University have found that almost one in 10 Scottish ... of more than 2,000 students studying //in west-central Scotland ... between 13-16 demonstrated behaviors that could lead to gambling ... of 11-12 years, 6 percent of the children had ...
... his team has carried out research on a specific genetic ... one in a million births. “About 1,500 to 2,000 Americans ... says Dr. Pearson. According to him neonatal diabetes, when detected ... controlling the blood sugar levels more effectively. ,Tablets instead ...
... for a while due to its eradication, yet people could ... not been vaccinated says a recent report.// ... had spread after an unvaccinated teenager contracted the virus and ... gathering. This spurred a large outbreak in USA, which also ...
... Government of New Zealand has released a 10-year ‘action plan’ ... and addiction services. // ,It was reported that the ... and stated that the primary part of the work was ... have their needs attended to earlier by way of a ...
... an alarm clock that promises to wake its users up when ... Sleep Phase Alarm Clock checks 30 minutes before the alarm is ... or light phase of sleep, say the manufacturers Infacory Innovations, who ... recently in Munich. ,With the help of a sensor ...
... which is grown in many Indian homes, and pudina have ... University of Rajasthan.// ,"We arrived at our conclusions after ... heads the research project. ,"Our research came ... first divided into two groups and then applied with a ...
Other Medicine News:Health News:Painless Control Of Blood Sugar Levels When Detected Early 2
(Date:5/23/2012)... ORANGE, N.J., May 23, 2012  Everett Laboratories, ... field of prenatal supplementation, today announced that it ... motion for a preliminary injunction in the United ... Laboratories, Inc., a specialty niche pharmaceutical company.  The ... infringing United States Patent No. 8,183,227 covering Everett,s ...
(Date:5/23/2012)... the nation,s leader in Pain Medication Monitoring Solutions®, ... manage compliance and ethics issues when working with ... a new website offering important regulatory compliance information. ... to provide the resources, support and services that ... – achieve better outcomes for their patients. For ...
(Date:5/23/2012)... HOUSTON, May 23, 2012 Kraton ... global producer of styrenic block copolymers or ... provider of specialized polymer materials, services and solutions, ... add Cariflex polyisoprene products to the PolyOne product ... Distribution as our distributor for Cariflex IR products ...
Breaking Medicine Technology:Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc. 2Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues 2Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues 3Cariflex™ Polyisoprene Products by Kraton Performance Polymers Added to PolyOne Distribution Product Line 2Cariflex™ Polyisoprene Products by Kraton Performance Polymers Added to PolyOne Distribution Product Line 3Genetic Marker for Aggressive Prostate Cancer Found 64353 1Genetic Marker for Aggressive Prostate Cancer Found 64353 2Genetic Marker for Aggressive Prostate Cancer Found 64353 3Top Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 64351 1Top Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 64351 2Top Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 64351 3Co Founder of Baby Einstein Files Open Records Complaint for Access to University of Washington Research 64349 1Co Founder of Baby Einstein Files Open Records Complaint for Access to University of Washington Research 64349 2Co Founder of Baby Einstein Files Open Records Complaint for Access to University of Washington Research 64349 3Co Founder of Baby Einstein Files Open Records Complaint for Access to University of Washington Research 64349 4
... Results,published this week in The Lancet show that ... 6, 11,16, 18) Recombinant Vaccine) was 100 percent ... by HPV,types 16 and 18, two types strongly ... observed in women who were not,infected with HPV ...
... VANCOUVER and SAN DIEGO, May 18, 2007 /PRNewswire-FirstCall/ ... for infectious,diseases will make a presentation of results ... study (see April 11, 2007,press release) in a ... being held in Washington, DC May 19-24,2007. Dr. ...
Other Medicine Technology:Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3
9 inch sharp bone hook with grip handle....
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
Beuse Zygomatic Arch Awl with slightly curved tip....
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
Medicine Products: